The following expression levels were significantly higher in leiomyosarcomas than in PTSMT (Table 2): WNT9B, GAS1, signaling factor desert hedgehog (DHH), the two Notch signaling pathway factors LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase provided (LFNG) and MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (MFNG), protein kinase cAMP-activated catalytic subunit alpha (PRKACA) and insulin-like growth factor 1 (IGF1). The gene discussed is WNT9B; the disease is leiomyosarcoma.